Parkinson Disease (PD): Clinical Trials

97 trials for Parkinson Disease (PD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

41 recruiting, 26 not yet recruiting, 16 completed, 7 active not recruiting. 54 Not applicable, 9 Phase 1, 9 Phase 2, 3 Early Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable54Recruiting 21, Completed 13, Not yet recruiting 12, Active not recruiting 5, Enrolling by invitation 2, Unknown 1
Phase 19Recruiting 5, Not yet recruiting 3, Withdrawn 1
Phase 29Recruiting 5, Not yet recruiting 4
Early Phase 13Recruiting 2, Not yet recruiting 1
Phase 32Recruiting 2
Phase 41Not yet recruiting 1

Follow Parkinson Disease (PD): new trials by email Literature Review of Parkinson Disease (PD) trials Research Report on Parkinson Disease (PD)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Exploring the Efficacy of the Effortful Swallow Maneuver for Improving Swallowing in People With PD
Effortful swallow - Dysphagia, Parkinson Disease (PD)
Not applicableNot yet recruitingUniversity of Alberta742027-01-012026-08-19
Probing Gut-Brain Communication in Parkinson's Disease
taVNS, Sham taVNS - Parkinson Disease (PD)
Not applicableNot yet recruitingSpaulding Rehabilitation Hospital452027-01-012026-10-08
Bayesian Optimization of DBS for Gait
Deep Brain Stimulation - Parkinson Disease (PD)
Early Phase 1RecruitingUniversity of Minnesota152026-12-012026-09-28
Passive Versus Active Music Therapy Parkinson's Disease
Passive music therapy, Active music therapy - Parkinson Disease (PD)
Not applicableNot yet recruitingUniversity of Alabama at Birmingham282026-11-012026-10-08
Digital Patient Engagement in Technology-Supported Neurorehabilitation
Stroke, Parkinson Disease (PD)
Not yet recruitingCatholic University, Italy1292026-10-012026-09-15
Sensor-Based Optimization of Therapy for Parkinson's Disease Patients With Motor Fluctuations
wearable-based adjustment therapy - Parkinson Disease (PD)
Not applicableNot yet recruitingAssistance Publique - Hôpitaux de Paris2182026-10-012026-09-02
Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study
Smartwatch and phone app - Parkinson Disease (PD), REM Sleep Behavior Disorder (iRBD)
Not yet recruitingQueen Mary University of London602026-10-012026-10-02
Parkinson's Disease in Type 1 Gaucher Disease
Parkinson Disease (PD), Type 1 Gaucher Disease
RecruitingIcahn School of Medicine at Mount Sinai1002026-10-012026-10-21
Effects of Transcutaneous Cervical Vagus Nerve Stimulation on Non-motor Symptoms in Parkinson's Disease
transcutaneous vagus nerve stimulation - Parkinson's Disease (PD), Parkinson Disease (PD)
Not applicableNot yet recruitingKyoungwon Baik152026-09-302026-09-24
Effects of Repetitive Transcranial Magnetic Stimulation (rTMS)-Primed Self-controlled Practice in People With Parkinson's Disease
Repetitive Transcranial Magnetic Stimulation (rTMS), Physical therapy - Parkinson Disease (PD)
Not applicableRecruitingNational Taiwan University Hospital902026-09-232026-09-22
Acute Effects of Capacitive-Resistive Radiofrequency Therapy in People With Parkinson's Disease
Capacitive Radiofrequency Therapy, Resistive Radiofrequency Therapy, Capacitive-Resistive Radiofrequency Therapy - Parkinson Disease (PD)
Not applicableRecruitingUniversidad San Jorge202026-09-212026-09-25
Idiopathic Parkinson's Disease: Interest of an Early Group-Based Cognitive Rehabilitation Program (LIFECOG-PD)
cognitive rehabilitation program - Parkinson Disease (PD)
Not applicableNot yet recruitingUniversity Hospital, Clermont-Ferrand242026-09-152026-09-10
MRI-Guided Temporal Interference Stimulation for Parkinson's Disease
Temporal Interference Stimulation (130 Hz) - Parkinson Disease (PD)
Not applicableNot yet recruitingTongji Hospital262026-09-152026-09-21
Synthetic Vasomotion for Glymphatic Enhancement
Active noninvasive vagus nerve stimulation, Sham noninvasive vagus nerve stimulation, Active intermittent hypercapnia - Parkinson Disease (PD)
Not applicableNot yet recruitingFlorida Institute for Human and Machine Cognition202026-09-012026-09-11
Comparison of Benzhexol and Procyclidine for Tremor in Tremor-Predominant Parkinson's Disease
Benzhexol, Procyclidine - Parkinson Disease (PD)
Not applicableRecruitingsafia bano882026-09-012026-09-14
Real-world Patient Experiences With Inbrija®
Levodopa inhalation powder - Parkinson Disease (PD), Parkinson's Disease
RecruitingMerz Therapeutics GmbH1202026-09-012026-10-02
Outlining Biological Effects of Subthalamic Deep Brain Stimulation in Parkinson's Disease Patients.
Deep brain stimulation surgery - Parkinson Disease (PD)
Not yet recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS902026-09-012026-06-29
Assessment of the Safety, Immunogenicity, and Pharmacodynamics of TRB-001 in Patients With Early Idiopathic Parkinson's Disease
TRB-001, Placebo - Parkinson Disease (PD), Idiopathic Parkinson's Disease
Phase 1RecruitingTridem Bioscience FlexCo362026-09-012026-09-24
Behavioral Intervention for Lifestyle Physical Activity in Parkinson's Disease
GET Up PD, Stretching and Flexibility - Parkinson Disease (PD)
Not applicableNot yet recruitingUniversity of Illinois at Chicago502026-08-012026-06-04
Short Term Effects of a Multimodal Intervention With RGM on Cognition in People With Parkinson's Disease.
Ronnie Gardiner Method - Parkinson Disease (PD), Cognition
Not applicableRecruitingUniversity Ghent202026-08-012026-10-07

Showing 20 of 97. Sign in to see all of them.

Narrower conditions

Parkinson Disease (97)  ·  Alzheimer Disease (4)  ·  Multiple Sclerosis (4)  ·  Tremor (4)  ·  Cognitive Dysfunction (3)  ·  Inflammation (3)  ·  Nervous System Diseases (3)  ·  REM Sleep Behavior Disorder (3)  ·  Amyotrophic Lateral Sclerosis (2)  ·  Autistic Disorder (2)  ·  Brain Diseases (2)  ·  Brain Injuries, Traumatic (2)  ·  Cerebral Palsy (2)  ·  Communication Disorders (2)  ·  Corticobasal Degeneration (2)

Broader conditions

Basal Ganglia Diseases (96)  ·  Central Nervous System Diseases (96)  ·  Parkinsonian Disorders (96)  ·  Synucleinopathies (96)  ·  Brain Diseases (95)  ·  Movement Disorders (95)  ·  Neurodegenerative Diseases (95)  ·  Nervous System Diseases (94)  ·  Pathological Conditions, Signs and Symptoms (28)  ·  Signs and Symptoms (20)  ·  Mental Disorders (17)  ·  Neurologic Manifestations (13)  ·  Neurocognitive Disorders (11)  ·  Pathologic Processes (9)  ·  Tauopathies (6)

Interventions

Amantadine (2)  ·  Control Groups (2)  ·  Transcranial Magnetic Stimulation (2)  ·  3-fluorobenzylguanidine (1)  ·  Blood Specimen Collection (1)  ·  Clozapine (1)  ·  Combined Modality Therapy (1)  ·  Deep Brain Stimulation (1)  ·  Dietary Supplements (1)  ·  Dihydroxyphenylalanine (1)  ·  Exercise (1)  ·  Genetic Therapy (1)  ·  GluN2C-2D antagonist UBP145 (1)  ·  Physical Therapy Modalities (1)  ·  Pliability (1)

Sponsors

Bezmialem Vakif University (2)  ·  Marmara University (2)  ·  National Taiwan University Hospital (2)  ·  Ruijin Hospital (2)  ·  University of Cadiz (2)  ·  AbbVie (1)  ·  Ankara University (1)  ·  Annemette Lokkegaard (1)  ·  Apeiron Research Center (1)  ·  Ashvattha Therapeutics, Inc. (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Beijing Tiantan Hospital (1)  ·  Bilinç Doğruöz Karatekin (1)  ·  Casa di Cura IGEA (1)  ·  Catholic University, Italy (1)

Countries

United States (16)  ·  China (12)  ·  Turkey (Türkiye) (12)  ·  Spain (9)  ·  France (7)  ·  Italy (5)  ·  Denmark (4)  ·  Taiwan (4)  ·  United Kingdom (4)  ·  Brazil (3)  ·  Pakistan (3)  ·  Austria (2)  ·  Canada (2)  ·  Australia (1)  ·  Belgium (1)

Top investigators

Amanda L Bressanelli, Academic (1)  ·  Arnab Altaf, MSDPT (1)  ·  Astrid J. Terkelsen, MD, DrMedSc, PhD, Professor (1)  ·  Ayla Fil (1)  ·  Carolyn Sue, PhD, MD (1)  ·  Christopher G Ballmann, PhD (1)  ·  Conor J Walsh, PhD (1)  ·  Daniel Chan, PhD, MD (1)  ·  David Grabli, Professor (1)  ·  Dr. Glen Cronett, PhD/MD (1)

Results publications

PMID 18846551, PMID 19058133, PMID 20574039, PMID 20582993, PMID 21843110, PMID 22785003, PMID 24253234, PMID 26347184, PMID 26381806, PMID 27669053, PMID 28409181, PMID 29131880, PMID 29178491, PMID 31370168, PMID 31377123, PMID 31571503, PMID 32162166, PMID 32827221, PMID 34588228, PMID 34950630, PMID 35483736, PMID 35837986, PMID 37310119, PMID 37868930, PMID 41193192, PMID 41838745

NIH funding

2023 (2), U01DK140933 (2), 2025 (1), P30AG022849 (1), R33AG086944 (1), U01DK140921 (1), U01DK140923 (1), U01DK140936 (1), U01DK140939 (1), U24DK140918 (1)